Pharmaceutical Investing Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Agriculture Investing Canbud Establishes R&D Partnership with Brock University for Climate Smart Sustainable Natural Fungi BioFertilizer
Life Science Investing Cardiol’s Pending Phase II/III COVID-19 Trial Medically Justified and Even More Timely
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
DEADLINE ALERT for XL, PLUG, NEPT, BLU: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Medical Device Investing Abbott's XIENCE Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy for High Bleeding Risk Patients
Physician-Led Webinar Sponsored by Perimeter Medical Imaging AI Highlights Advancements in Intraoperative Specimen Imaging
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
